Cargando…

Cell Technologies in the Stress Urinary Incontinence Correction

The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiborodin, Igor, Yarin, Gennadiy, Marchukov, Sergey, Pichigina, Aleksandra, Lapii, Galina, Krasil’nikov, Sergey, Senchukova, Svetlana, Ryaguzov, Maxim, Vilgelmi, Inna, Bakarev, Maksim, Maiborodina, Vitalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869383/
https://www.ncbi.nlm.nih.gov/pubmed/35203518
http://dx.doi.org/10.3390/biomedicines10020309
_version_ 1784656484706025472
author Maiborodin, Igor
Yarin, Gennadiy
Marchukov, Sergey
Pichigina, Aleksandra
Lapii, Galina
Krasil’nikov, Sergey
Senchukova, Svetlana
Ryaguzov, Maxim
Vilgelmi, Inna
Bakarev, Maksim
Maiborodina, Vitalina
author_facet Maiborodin, Igor
Yarin, Gennadiy
Marchukov, Sergey
Pichigina, Aleksandra
Lapii, Galina
Krasil’nikov, Sergey
Senchukova, Svetlana
Ryaguzov, Maxim
Vilgelmi, Inna
Bakarev, Maksim
Maiborodina, Vitalina
author_sort Maiborodin, Igor
collection PubMed
description The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals with incontinence have shown promising results, but the procedures require further optimization, and more research is needed to focus on the clinical phase. The MSC use appears to be a feasible, safe, and effective method of treatment for patients with urinary incontinence. However, the best mode for application of cell technology is still under study. Most clinical investigations have been performed on only a few patients and during rather short follow-up periods, which, together with an incomplete knowledge of the mechanisms of MSC action, does not make it possible for their widespread implementation. The technical details regarding the MSC application remain to be identified in more rigorous preclinical and clinical trials.
format Online
Article
Text
id pubmed-8869383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88693832022-02-25 Cell Technologies in the Stress Urinary Incontinence Correction Maiborodin, Igor Yarin, Gennadiy Marchukov, Sergey Pichigina, Aleksandra Lapii, Galina Krasil’nikov, Sergey Senchukova, Svetlana Ryaguzov, Maxim Vilgelmi, Inna Bakarev, Maksim Maiborodina, Vitalina Biomedicines Review The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals with incontinence have shown promising results, but the procedures require further optimization, and more research is needed to focus on the clinical phase. The MSC use appears to be a feasible, safe, and effective method of treatment for patients with urinary incontinence. However, the best mode for application of cell technology is still under study. Most clinical investigations have been performed on only a few patients and during rather short follow-up periods, which, together with an incomplete knowledge of the mechanisms of MSC action, does not make it possible for their widespread implementation. The technical details regarding the MSC application remain to be identified in more rigorous preclinical and clinical trials. MDPI 2022-01-28 /pmc/articles/PMC8869383/ /pubmed/35203518 http://dx.doi.org/10.3390/biomedicines10020309 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Maiborodin, Igor
Yarin, Gennadiy
Marchukov, Sergey
Pichigina, Aleksandra
Lapii, Galina
Krasil’nikov, Sergey
Senchukova, Svetlana
Ryaguzov, Maxim
Vilgelmi, Inna
Bakarev, Maksim
Maiborodina, Vitalina
Cell Technologies in the Stress Urinary Incontinence Correction
title Cell Technologies in the Stress Urinary Incontinence Correction
title_full Cell Technologies in the Stress Urinary Incontinence Correction
title_fullStr Cell Technologies in the Stress Urinary Incontinence Correction
title_full_unstemmed Cell Technologies in the Stress Urinary Incontinence Correction
title_short Cell Technologies in the Stress Urinary Incontinence Correction
title_sort cell technologies in the stress urinary incontinence correction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869383/
https://www.ncbi.nlm.nih.gov/pubmed/35203518
http://dx.doi.org/10.3390/biomedicines10020309
work_keys_str_mv AT maiborodinigor celltechnologiesinthestressurinaryincontinencecorrection
AT yaringennadiy celltechnologiesinthestressurinaryincontinencecorrection
AT marchukovsergey celltechnologiesinthestressurinaryincontinencecorrection
AT pichiginaaleksandra celltechnologiesinthestressurinaryincontinencecorrection
AT lapiigalina celltechnologiesinthestressurinaryincontinencecorrection
AT krasilnikovsergey celltechnologiesinthestressurinaryincontinencecorrection
AT senchukovasvetlana celltechnologiesinthestressurinaryincontinencecorrection
AT ryaguzovmaxim celltechnologiesinthestressurinaryincontinencecorrection
AT vilgelmiinna celltechnologiesinthestressurinaryincontinencecorrection
AT bakarevmaksim celltechnologiesinthestressurinaryincontinencecorrection
AT maiborodinavitalina celltechnologiesinthestressurinaryincontinencecorrection